Search Results - Ying-tao Lin
- Showing 1 - 1 results of 1
-
1
Cost-Effectiveness of Nivolumab Immunotherapy vs. Paclitaxel or Docetaxel Chemotherapy as Second-Line Therapy in Advanced Esophageal Squamous Cell Carcinoma in China by Ying-tao Lin, Tian-xiu Liu, Jian Chen, Chang Wang, Ying Chen
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book